Drug:
Reaction: PRODUCT USE ISSUE
20260101 - 20261231
No. 201 - 300
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 201 | 26922297 |
US |
24 | |
Product use issue, |
||||
ISOTRETINOIN, |
||||
| 202 | 26922332 |
US |
46 | |
Gout, Product use issue, Vomiting, Nausea, Diarrhoea, Dehydration, |
||||
TIRZEPATIDE, |
||||
| 203 | 26922334 |
CA |
58 | 2 |
Thrombocytopenia, Upper respiratory tract infection, Rheumatoid arthritis, Pain, Psoriasis, Pyrexia, Rash, Retching, Temperature regulation disorder, Treatment failure, Off label use, Product use issue, Prescribed overdose, Overdose, |
||||
QUETIAPINE FUMARATE, QUETIAPINE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, FUROSEMIDE, OXYCODONE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VITAMIN C, VITAMIN C, VITAMIN C, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE, MORPHINE SULFATE, MORPHINE SULFATE, MORPHINE SULFATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM, SENNOSIDES, ALBUTEROL SULFATE, ALBUTEROL SULFATE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ETANERCEPT, GABAPENTIN, ADALIMUMAB, PROGESTERONE, PROGESTERONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, TEMAZEPAM, TEMAZEPAM, SENNOSIDES 8.6 MG TABLETS, SENNOSIDES, SENNA LEAF, SENNA, SENNA LEAF, SENNA LEAF, SENNA LEAF, TEMAZEPAM, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ALBUTEROL SULFATE, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, METHYLPREDNISOLONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MORPHINE SULFATE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, PROGESTERONE, NORTRIPTYLINE HYDROCHLORIDE, |
||||
| 204 | 26922515 |
US |
2 | |
Cardiac flutter, Weight decreased, Product use issue, |
||||
ORAL SEMAGLUTIDE, |
||||
| 205 | 26922554 |
US |
45 | 2 |
Product use issue, Stress, |
||||
| 206 | 26922573 |
US |
||
Feeling abnormal, Product use issue, |
||||
NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, |
||||
| 207 | 26922597 |
US |
2 | 2 |
Product use issue, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, VALPROIC ACID, |
||||
| 208 | 26922650 |
GB |
47 | |
Diabetes mellitus, Colitis, Condition aggravated, Malaise, Product use issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 209 | 26922679 |
CA |
56 | |
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Condition aggravated, Delirium, Diabetes mellitus, Diarrhoea, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Fatigue, Fibromyalgia, Gait disturbance, Glossodynia, Grip strength decreased, Hand deformity, Liver injury, Mobility decreased, Muscular weakness, Nausea, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Arthropathy, Psoriatic arthropathy, Rheumatoid arthritis, Seronegative arthritis, Swelling, Synovitis, Type 2 diabetes mellitus, Weight decreased, Wheezing, Oedema, Hypersensitivity, Rash, Systemic lupus erythematosus, Urticaria, Visual impairment, Vomiting, Weight increased, Upper respiratory tract infection, Wound infection, Treatment failure, Therapeutic product effect decreased, Maternal exposure during pregnancy, Underdose, Product use issue, Prescribed underdose, Product use in unapproved indication, Prescribed overdose, Off label use, Contraindicated product administered, Drug ineffective, Drug tolerance decreased, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, LEFLUNOMIDE, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOFACITINIB, TOFACITINIB CITRATE, TOFACITINIB CITRATE, TOFACITINIB CITRATE, CALCIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SULFASALAZINE, |
||||
| 210 | 26922870 |
US |
55 | 2 |
Keratomileusis, Prescribed underdose, Inappropriate schedule of product administration, Product prescribing issue, Product use issue, |
||||
PERFLUOROHEXYLOCTANE, PERFLUOROHEXYLOCTANE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 211 | 26923022 |
CN |
61 | 1 |
Hepatic function abnormal, Product use issue, |
||||
ERTUGLIFLOZIN, ERTUGLIFLOZIN, |
||||
| 212 | 26923150 |
2 | ||
Burning sensation, Product administration error, Product deposit, Product use in unapproved indication, Product use issue, |
||||
TESTOSTERONE CYPIONATE, |
||||
| 213 | 26923210 |
CA |
43 | 2 |
Abdominal discomfort, Diarrhoea, Osteoarthritis, Off label use, Duodenal ulcer perforation, Facet joint syndrome, Muscular weakness, Urticaria, Breast cancer stage II, Pneumonia, Folliculitis, Neck pain, Night sweats, Drug intolerance, Therapeutic product effect decreased, Depression, Therapeutic product effect incomplete, C-reactive protein increased, Migraine, Rash, Peripheral venous disease, Weight increased, Fibromyalgia, Drug hypersensitivity, Gastrooesophageal reflux disease, Asthenia, Wheezing, Maternal exposure during pregnancy, Wound, Blister, Treatment failure, Taste disorder, Inflammation, Drug ineffective, Pain in extremity, Product use in unapproved indication, Arthralgia, Onychomadesis, Psoriatic arthropathy, Stomatitis, Gait inability, Type 2 diabetes mellitus, Paraesthesia, Pain, Dry mouth, Bursitis, Dizziness, Synovitis, Arthropathy, Product quality issue, Live birth, Blepharospasm, Pericarditis, Epilepsy, Anti-cyclic citrullinated peptide antibody positive, Hypoaesthesia, Injury, Abdominal pain upper, Rheumatic fever, Systemic lupus erythematosus, Contraindicated product administered, Wound infection, General physical health deterioration, Pemphigus, Vomiting, Confusional state, Rheumatoid arthritis, Back injury, Swelling, Blood cholesterol increased, Memory impairment, Product use issue, Sleep disorder, Alopecia, Peripheral swelling, |
||||
AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, APREMILAST, APREMILAST, APREMILAST, CYANOCOBALAMIN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, TRETINOIN, TRETINOIN, MAGNESIUM, NICOTINAMIDE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, MILNACIPRAN HYDROCHLORIDE, ERGOCALCIFEROL, ERGOCALCIFEROL, MIRABEGRON, MIRABEGRON, MIRABEGRON, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, BUPRENORPHINE, CALCIUM GLUCONATE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, AZELAIC ACID, 12%AZELAIC ACID, 14%AZELAIC ACID, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, NEOMYCIN OINTMENT, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, BETAMETHASONE VALERATE, BETAMETHASONE VALERATE FOAM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, THIAMINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, TOPIRAMATE, PHOSPHORUS, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PYRIDOXINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, PAROXETINE HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, FLUTICASONE FUROATE, AZATHIOPRINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CANDESARTAN CILEXETIL, CANDESARTAN, CANDESARTAN, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ERGOCALCIFEROL, ERGOCALCIFEROL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, FLUTICASONE FUROATE, VITAMIN C, VITAMIN C, VITAMIN C, VITAMIN C, MAGNESIUM CARBONATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, LEVOMILNACIPRAN HYDROCHLORIDE, LEVOMILNACIPRAN HYDROCHLORIDE, LEVOMILNACIPRAN HYDROCHLORIDE, CALCIUM, CALCIUM, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, DEXPANTHENOL, DEXPANTHENOL, OXYCODONE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, INFLIXIMAB, INFLIXIMAB, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, ACETAMINOPHEN AND CODEINE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, TRAZODONE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, ERENUMAB-AOOE, ERENUMAB-AOOE, ATOMOXETINE HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, BUPRENORPHINE, |
||||
| 214 | 26923240 |
US |
80 | |
Wrong technique in product usage process performed in error, Device delivery system issue, Device deposit issue, Device breakage, Product use issue, Off label use, Drug ineffective, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 215 | 26923580 |
CN |
42 | 2 |
Myelosuppression, Product use issue, |
||||
PEMBROLIZUMAB, GEMCITABINE HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, |
||||
| 216 | 26923582 |
US |
2 | |
Device malfunction, Overdose, Device use error, Product use issue, Malaise, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 217 | 26924001 |
US |
80 | 1 |
Dyspnoea, Inability to afford medication, Product dose omission issue, Product use issue, |
||||
ENSIFENTRINE, |
||||
| 218 | 26924044 |
US |
2 | |
Headache, Cough, Diarrhoea, Decreased appetite, Abdominal pain upper, Pain in extremity, Asthenia, Dyspnoea exertional, Wheezing, Product use issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, GABAPENTIN, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, OXYCODONE HYDROCHLORIDE, OXYCODONE, MEGESTROL ACETATE, SPIRONOLACTONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, MIRTAZAPINE, SERTRALINE HYDROCHLORIDE, MACITENTAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SOTATERCEPT-CSRK, OXYGEN, 0XYGEN, MONTELUKAST SODIUM, MONTELUKAST, CETIRIZINE HCL, CETIRIZINE HYDROCHLORIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, AMLODIPINE BESYLATE, FUROSEMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 219 | 26924049 |
GB |
1 | |
Hospitalisation, Mental disorder, Dependence, Malaise, Emotional disorder, Cystic fibrosis, Product use issue, |
||||
IVACAFTOR, MANNITOL, DORNASE ALFA, |
||||
| 220 | 26924391 |
US |
59 | 2 |
Inflammation, Condition aggravated, Pain, Treatment noncompliance, Product use issue, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 221 | 26924518 |
IN |
38 | 2 |
Hepatotoxicity, Hepatomegaly, Dyspepsia, Product dose omission issue, Product availability issue, Off label use, Product use issue, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, |
||||
| 222 | 26924684 |
US |
30 | 2 |
Hepatic cancer metastatic, Off label use, Product use issue, Abdominal discomfort, Death, |
||||
MITOTANE, METYRAPONE, VITAMIN C, ACETAMINOPHEN, EDOXABAN TOSYLATE, OMEPRAZOLE MAGNESIUM, LISINOPRIL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, EPLERENONE, AMLODIPINE, ERGOCALCIFEROL, STANDARDIZED SENNA CONCENTRATE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, MELATONIN, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LORAZEPAM, OSILODROSTAT, GABAPENTIN, FERROUS SULFATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, |
||||
| 223 | 26924765 |
US |
62 | 2 |
Weight increased, Product use issue, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 224 | 26924921 |
US |
73 | 2 |
Diarrhoea, Product use issue, Product prescribing issue, |
||||
RIFAXIMIN, NEBIVOLOL HYDROCHLORIDE, |
||||
| 225 | 26924989 |
US |
67 | 1 |
Product dose omission issue, Therapeutic product effect decreased, Product use issue, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 226 | 26925209 |
US |
2 | |
Incorrect product administration duration, Product use issue, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CALCIUM, ERGOCALCIFEROL, |
||||
| 227 | 26925698 |
US |
51 | 2 |
Needle issue, Product use issue, Cough, Inappropriate schedule of product administration, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 228 | 26926133 |
US |
2 | |
Abdominal pain upper, Product use issue, Food intolerance, Product dispensing issue, |
||||
ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, ORAL SEMAGLUTIDE, |
||||
| 229 | 26926145 |
US |
2 | |
Vomiting, Product use issue, |
||||
| 230 | 26926252 |
US |
46 | 1 |
Peripheral swelling, Product use issue, |
||||
| 231 | 26926260 |
US |
||
Pulmonary function test decreased, Pneumothorax, Pneumonia, Product use issue, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 232 | 26926515 |
GB |
36 | |
Abortion spontaneous, Product use issue, Product dose omission issue, Product prescribing issue, Maternal exposure during pregnancy, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, |
||||
| 233 | 26914737 |
KR |
||
Cytomegalovirus viraemia, Headache, Product use issue, |
||||
RITUXIMAB, ZANUBRUTINIB, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, CARBOPLATIN, ETOPOSIDE, ETOPOSIDE, |
||||
| 234 | 26914755 |
CA |
41 | 1 |
Joint swelling, Rheumatoid nodule, Mobility decreased, Musculoskeletal stiffness, Insomnia, Joint injury, Liver function test increased, Malaise, Musculoskeletal disorder, Mucosal inflammation, Nausea, Osteomyelitis, Pain, Panniculitis, Peripheral swelling, Psoriatic arthropathy, Pulmonary fibrosis, Rash, Product use issue, Overdose, Off label use, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, BISOPROLOL FUMARATE, ALENDRONATE SODIUM, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, AZATHIOPRINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CYCLOSPORINE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, ABATACEPT, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, CYCLOSPORINE, CYCLOSPORINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, GOLIMUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, GOLD, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, IBUPROFEN, IBUPROFEN AND DIPHENHYDRAMINE CITRATE, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, APREMILAST, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PIROXICAM, FOLIC ACID, RISEDRONATE SODIUM, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FEBUXOSTAT, FEBUXOSTAT TABLETS 40 MG, FEBUXOSTAT TABLETS 80 MG, FOLIC ACID, FOLIC ACID, DIMENHYDRINATE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE HYDROCHLORIDE, OXYCODONE, OXYCODONE, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, FEBUXOSTAT, ERGOCALCIFEROL, ERGOCALCIFEROL, TOFACITINIB, COLCHICINE, COLCHICINE, COLCHICINE, RISEDRONATE SODIUM, RISEDRONATE SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, AZATHIOPRINE, |
||||
| 235 | 26914954 |
CA |
43 | |
Oedema peripheral, Osteoporosis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Rheumatic fever, Pneumonia, Retinitis, Red blood cell sedimentation rate increased, Osteoarthritis, Product use issue, Product use in unapproved indication, Prescribed underdose, Prescribed overdose, Off label use, Intentional product use issue, Underdose, Suspected off label use, Suspected off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, OXYCODONE, OXYCODONE, OXYCODONE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 236 | 26915151 |
US |
84 | 2 |
Depressed level of consciousness, Medication error, Incorrect route of product administration, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 237 | 26915152 |
US |
2 | 2 |
Depressed level of consciousness, Eye disorder, Neurological symptom, Bradycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 238 | 26915197 |
US |
3 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 239 | 26915199 |
US |
3 | 2 |
Depressed level of consciousness, Hypothermia, Bradycardia, Hypotension, Pallor, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 240 | 26915202 |
US |
7 | 2 |
Depressed level of consciousness, Pyrexia, Hyperthermia, Hypothermia, Miosis, Tachycardia, Respiratory depression, Bradycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 241 | 26915319 |
US |
79 | 1 |
Depressed level of consciousness, Bradycardia, Hypotension, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 242 | 26915320 |
US |
2 | 1 |
Accidental exposure to product by child, Product use issue, Product storage error, |
||||
BRIMONIDINE TARTRATE, |
||||
| 243 | 26915321 |
US |
02 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 244 | 26915322 |
US |
74 | 1 |
Depressed level of consciousness, Confusional state, Bradycardia, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 245 | 26915323 |
US |
21 | 1 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 246 | 26915324 |
US |
3 | 2 |
Depressed level of consciousness, Product use issue, Accidental exposure to product by child, |
||||
BRIMONIDINE TARTRATE, |
||||
| 247 | 26915325 |
US |
2 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 248 | 26915336 |
US |
35 | 2 |
Seizure, Road traffic accident, Product use issue, Inappropriate schedule of product administration, Therapy interrupted, |
||||
ESLICARBAZEPINE ACETATE, |
||||
| 249 | 26915364 |
US |
2 | 1 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
| 250 | 26915366 |
US |
11 | 1 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 251 | 26915645 |
EU |
43 | 1 |
Disease progression, Haematopoietic stem cell mobilisation, Hodgkin^s disease refractory, Nephropathy toxic, White blood cell count abnormal, C-reactive protein abnormal, Blood lactate dehydrogenase abnormal, Platelet count abnormal, Haemoglobin abnormal, Pyrexia, Night sweats, Product use issue, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETOPOSIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, DOXORUBICIN, VINCRISTINE SULFATE, VINCRISTINE SULFATE, PREDNISONE, PREDNISONE, CISPLATIN, CYTARABINE, CYTARABINE, OXALIPLATIN, VINORELBINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, LORATADINE, LORATADINE ORAL, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, BRENTUXIMAB VEDOTIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, PEMBROLIZUMAB, BRENTUXIMAB VEDOTIN, IFOSFAMIDE, IFOSFAMIDE FOR INJECTION, VINORELBINE, PREDNISONE, |
||||
| 252 | 26915678 |
16 | ||
Pustule, Inflammation, Product use issue, Off label use, Product ineffective for unapproved use, |
||||
| 253 | 26915717 |
US |
55 | |
Product use issue, |
||||
NIVOLUMAB, |
||||
| 254 | 26916038 |
US |
2 | |
Drug interaction, Product use issue, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, ZIPRASIDONE, |
||||
| 255 | 26916081 |
US |
10 | 2 |
Depressed level of consciousness, Medication error, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 256 | 26916131 |
US |
1 | |
Product use issue, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, |
||||
| 257 | 26916135 |
US |
1 | |
Product use issue, Unintentional use for unapproved indication, Product administration error, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 258 | 26916150 |
US |
14 | 1 |
Accidental exposure to product, Product use issue, |
||||
| 259 | 26916160 |
CA |
43 | 2 |
Fibromyalgia, Folliculitis, Gait disturbance, Fatigue, Arthropathy, Autoimmune disorder, Breast cancer stage II, Abdominal discomfort, Hypocholesterolaemia, Retinitis, Visual impairment, Product use issue, Incorrect route of product administration, Medication error, Off label use, |
||||
DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, OXYCODONE HYDROCHLORIDE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREGABALIN, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, CANDESARTAN, CANDESARTAN, CANDESARTAN, CANDESARTAN, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, OXYCODONE, OXYCODONE, OXYCODONE, CELECOXIB, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, EPIC MEDICAL MAGNESIUM CITRATE ORAL SOLUTION - LEMON, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, EQUATE MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 260 | 26916222 |
US |
18 | 1 |
Depressed level of consciousness, Agitation, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 261 | 26916224 |
US |
20 | 1 |
Suspected suicide, Hypertension, Intentional product misuse, Product use issue, |
||||
| 262 | 26916278 |
US |
1 | 1 |
Depressed level of consciousness, Medication error, Wrong product administered, Product use issue, |
||||
| 263 | 26916279 |
US |
2 | 1 |
Depressed level of consciousness, Bradycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 264 | 26916280 |
US |
18 | 2 |
Depressed level of consciousness, Product use issue, Accidental exposure to product, |
||||
| 265 | 26916281 |
US |
12 | 2 |
Depressed level of consciousness, Pallor, Accidental exposure to product, Product use issue, |
||||
| 266 | 26916290 |
US |
2 | |
Weight increased, Product use issue, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 267 | 26916293 |
US |
1 | |
Product use issue, Diarrhoea, Abdominal pain upper, Vomiting, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 268 | 26916379 |
US |
3 | 2 |
Depressed level of consciousness, Adverse event, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 269 | 26916384 |
US |
1 | 2 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 270 | 26916385 |
US |
3 | 2 |
Depressed level of consciousness, Bradycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 271 | 26916386 |
US |
7 | |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 272 | 26916702 |
US |
1 | |
Poisoning deliberate, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 273 | 26916724 |
EU |
35 | 1 |
Influenza like illness, C-reactive protein increased, Troponin T increased, Headache, Product use in unapproved indication, Product use issue, |
||||
CLOZAPINE, OLANZAPINE, ESCITALOPRAM, ESCITALOPRAM OXALATE, ESCITSLOPRAM, AMLODIPINE, SIMVASTATIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, EMPAGLIFLOZIN, |
||||
| 274 | 26916752 |
US |
2 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
| 275 | 26916756 |
US |
1 | 1 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 276 | 26916976 |
US |
62 | 1 |
Bradycardia, Hypertension, Hypotension, Adverse drug reaction, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 277 | 26917016 |
US |
7 | 2 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 278 | 26917018 |
US |
5 | 2 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
| 279 | 26917148 |
US |
72 | 1 |
Depressed level of consciousness, Bradycardia, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 280 | 26917149 |
US |
78 | 1 |
Somnolence, Lethargy, Bradycardia, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 281 | 26917182 |
US |
55 | 1 |
Shock, Tongue ulceration, Skin fissures, Muscle spasms, Product use issue, |
||||
BUDESONIDE, BUDESONIDE, BUDESONIDE, ALBUTEROL SULFATE, ALBUTEROL, AMLODIPINE BESYLATE, AZELASTINE, BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE, LOSARTAN, MIRABEGRON, ROSUVASTATIN, |
||||
| 282 | 26917196 |
US |
20 | 2 |
Accidental exposure to product, Product use issue, |
||||
| 283 | 26917197 |
US |
15 | 2 |
Depressed level of consciousness, Pallor, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 284 | 26917198 |
US |
2 | 1 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
| 285 | 26917405 |
US |
5 | 1 |
Depressed level of consciousness, Respiratory depression, Bradycardia, Hypotension, Product use issue, Accidental exposure to product by child, |
||||
BRIMONIDINE TARTRATE, |
||||
| 286 | 26917406 |
US |
02 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 287 | 26917410 |
US |
2 | 2 |
Depressed level of consciousness, Bradycardia, Pallor, Accidental exposure to product by child, Product use issue, |
||||
| 288 | 26917413 |
US |
03 | 2 |
Depressed level of consciousness, Tachycardia, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 289 | 26917415 |
US |
05 | 1 |
Depressed level of consciousness, Pallor, Medication error, Wrong product administered, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 290 | 26917457 |
US |
23 | 1 |
Depressed level of consciousness, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 291 | 26917463 |
US |
4 | 2 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 292 | 26917464 |
US |
2 | 1 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
| 293 | 26917501 |
US |
23 | 1 |
Depressed level of consciousness, Hypotension, Accidental exposure to product, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 294 | 26917607 |
US |
52 | 2 |
Depressed level of consciousness, Agitation, Hypoaesthesia, Accidental exposure to product, Product use issue, |
||||
| 295 | 26917651 |
US |
2 | 1 |
Depressed level of consciousness, Accidental exposure to product by child, Product use issue, |
||||
BRIMONIDINE TARTRATE, |
||||
| 296 | 26917715 |
US |
19 | 2 |
Suspected suicide, Intentional product misuse, Product use issue, |
||||
| 297 | 26917716 |
US |
31 | 1 |
Suspected suicide, Somnolence, Lethargy, Nausea, Tachycardia, Product use issue, Intentional product misuse, |
||||
BRIMONIDINE TARTRATE, |
||||
| 298 | 26917805 |
US |
2 | |
Product dose omission issue, Product use issue, |
||||
ILOPERIDONE, |
||||
| 299 | 26917809 |
US |
1 | |
Product use issue, Product dose omission issue, |
||||
ILOPERIDONE, |
||||
| 300 | 26917811 |
US |
18 | 1 |
Product dose omission issue, Product use issue, |
||||
ILOPERIDONE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30